Filter
Top Products
7Medical Information
English
Warnings Related to Treatment
!
WARNING
• If you stop your CPAP or bilevel treatment, your sleep apnea will return
immediately.
• Always consult your clinician if you expect to be in a situation where you
cannot use your VPAP Malibu unit.
• If you are admitted to a hospital or prescribed any other form of medical
treatment, always inform the medical staff that you are being treated with
CPAP or bilevel. It is also important to contact the clinician who is treating
you for sleep apnea.
• If you experience an infection of the upper respiratory tract, middle ear, or
sinuses, contact your clinician before continuing your CPAP or bilevel
treatment. You may be advised to stop treatment until the infection has
cleared. If you continue with treatment during an infection, be sure to clean
your mask and tubing after every use.
Cautions
The following are general cautions. Specific cautions appear next to the relevant
instructions in this guide.
!
CAUTION
• Do not open the VPAP Malibu case. There are no user serviceable parts
inside. Repairs and internal servicing should only be performed by an
authorized service agent.
Possible Side Effects
The VPAP Malibu flow generator is designed to help you have a good night’s
sleep. However, you need to be aware of possible problems that may arise
during CPAP or bilevel treatment.
!
WARNING
Consult your clinician immediately if you experience any of the following
symptoms during your CPAP or bilevel treatment:
• headache
• middle ear or sinus discomfort
• dryness of the nose, mouth, or throat
• feeling bloated due to air swallowing
• air continually leaking out of the mouth while sleeping
• recurrence of any sleep apnea symptoms while on CPAP or bilevel.
Skin irritation may occur from sensitivity to the mask materials or from
excessively tight headgear straps. A correctly fitted mask and appropriately
adjusted straps will often prevent skin irritation. If problems persist, contact your
clinician for advice.
268106r1.book Page 7 Thursday, November 30, 2006 2:35 PM